Newly licensed vaccine, ‘milestone in the fight’ against Ebola in Africa, UN health agency
Four countries in Africa have licensed an Ebola vaccine to “cement hard-fought progress” in keeping their people safe from the deadly disease, the UN health agency said on Friday. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - February 14, 2020 Category: International Medicine & Public Health Source Type: news

It ’s Not Too Late to Prepare for COVID-19
By Dr. Lisa Stone, Epidemiology Adviser ; Robert Salerno, Director, Global Health Security Publio Gonzalez, a biologist with the Gorgas Institute, holds a bat in Meteti, Panama, June 6, 2018, as part an Emerging Infectious Diseases Training Event (U.S. Air Force photo by Senior Airman Dustin Mullen).February 11, 2020A disease spillover event, when a virus moves from animal to human hosts, can cause significant human illness. The coronavirus (COVID-19) seems to have spilled over sometime in late 2019, at a wildlife market in Wuhan, China, leading to more than 40,000 confirmed cases and at least 910 reported deaths&nbs...
Source: IntraHealth International - February 11, 2020 Category: International Medicine & Public Health Authors: kseaton Tags: Infectious Diseases Global Health Security Source Type: news

Johnson & Johnson Announces Collaboration with U.S. Department of Health & Human Services to Accelerate Development of a Potential Novel Coronavirus Vaccine
NEW BRUNSWICK, N.J., February 11, 2020 – Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will further expedite its investigational coronavirus vaccine program through an expanded collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health & Human Services. The collaborative partnership with BARDA builds on Johnson & Johnson’s multipronged response to the new coronavirus disease (COVID-19) outbreak. In addition to Janssen’s ef...
Source: Johnson and Johnson - February 11, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Coronavirus Researchers Are Using High-Tech Methods to Predict Where the Virus Might Go Next
As the deadly 2019-nCov coronavirus spreads, raising fears of a worldwide pandemic, researchers and startups are using artificial intelligence and other technologies to predict where the virus might appear next — and even potentially sound the alarm before other new, potentially threatening viruses become public health crises. “What we’re doing currently with Coronavirus is really trying to get an understanding of what’s happening on the ground through as many sources as we can get our hands on,” says John Brownstein, chief innovation officer at Boston Children’s Hospital and a professor...
Source: TIME: Health - February 11, 2020 Category: Consumer Health News Authors: Alejandro de la Garza Tags: Uncategorized 2019-nCoV coronavirus MSFTAI2019 onetime Source Type: news

The Coronavirus Outbreak Should Bring Out the Best in Humanity
Pandemics are perversely democratic. They’re nasty, lethal and sneaky, but they don’t discriminate. No matter your age, ethnicity, religion, gender, or nation, you’re a part of the pathogenic constituency. That shared vulnerability, and the resulting human collectivism—a universal response to a universal threat—is newly and vividly evident in the face of the now-global outbreak of the novel coronavirus known as 2019-nCoV. As of writing, there have been over 30,000 diagnosed cases and over 630 related deaths. A virus that emerged in a single city, Wuhan, China—indeed, in a single crowded ...
Source: TIME: Health - February 8, 2020 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized 2019-nCoV Infectious Disease Source Type: news

How Our Modern World Creates Outbreaks Like Coronavirus
“Everyone knows that pestilences have a way of recurring in the world,” observes Albert Camus in his novel The Plague. “Yet somehow we find it hard to believe in ones that crash down on our heads from a blue sky. There have been as many plagues as wars in history; yet plagues and wars always take people by surprise.” Camus was imagining a fictional outbreak of plague in 1948 in Oran, a port city in northwest Algeria. But at a time when the world is reeling from a very real microbial emergency sparked by the emergence of a novel coronavirus in Wuhan, central China, his observations are as pertinent a...
Source: TIME: Health - February 7, 2020 Category: Consumer Health News Authors: Mark Honigsbaum Tags: Uncategorized 2019-nCoV health ideas Source Type: news

Past Outbreaks Provide a Roadmap for U.S. Government Response to Coronavirus Threat
While the threat of the new coronavirus in the United States remains limited, a network of U.S. government agencies are already furiously ramping up efforts to contain the disease, should an outbreak occur. “We are working to keep the risk low,” said Health and Human Services Secretary Alex Azar, who is leading the federal government’s response, at a press conference Friday. So far, the overwhelming number of new cases of the virus, which originated in Wuhan, China, remain in China. There are only 11 confirmed cases in the U.S. The good news, some officials and infectious disease experts tell TIME, is t...
Source: TIME: Health - February 4, 2020 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized Source Type: news

The Future of Health Care in Rwanda Starts with a Strong Government Partnership
By Samson Radeny, Chief of party, Ingobyi Project, Rwanda ; Katherine Seaton, Editorial Officer Photo by Charles Harris for IntraHealth International.February 13, 2020Just a decade ago, Rwanda struggled to provide high-quality health services. But when the Millennium and Sustainable Development Goals pushed for change, Rwanda was focused, proactive, and determined to provide better for its 12 million people. Now, the country is an example of how hopes for better health care can become a reality.In the past two decades, the maternal mortality rate in Rwanda hasdropped from 1,071 to 210 deaths per 100,000 live births&n...
Source: IntraHealth International - February 4, 2020 Category: International Medicine & Public Health Authors: kseaton Tags: Infectious Diseases Maternal, Newborn, & Child Health Digital Health Leadership and Governance IntraHealth ' s 40th Anniversary Community Health Workers Source Type: news

Why We Are So Ill-Prepared for A Possible Pandemic Like Coronavirus
We were surprised in 2002 when a new coronavirus called SARS emerged from southern China and spread to 17 countries, causing more than 8,000 disease cases and nearly 800 deaths. We were surprised in 2009 when a new H1N1 influenza strain emerged in Mexico and caused worldwide panic. We were surprised in 2014 when Ebola virus broke out in three West African countries, with nearly 30,000 cases and more than 11,000 deaths. And here we are now, facing the 2019-nCoV coronavirus outbreak, on the verge of becoming a worldwide pandemic, wthin China reporting over 20,000 cases and nearly 500 deaths. Three years ago in a book, Deadl...
Source: TIME: Health - February 4, 2020 Category: Consumer Health News Authors: Michael T. Osterholm and Mark Olshaker Tags: Uncategorized 2019-nCoV health ideas Source Type: news

Doctors in China Are Starting Human Trials for a Coronavirus Treatment
China has kick-started a clinical trial to speedily test a drug for the novel coronavirus infection as the nation rushes therapies for those afflicted and scours for vaccines to protect the rest. Remdesivir, a new antiviral drug by Gilead Sciences Inc. aimed at infectious diseases such Ebola and SARS, will be tested by a medical team from Beijing-based China-Japan Friendship Hospital for efficacy in treating the deadly new strain of coronavirus, a hospital spokeswoman told Bloomberg News Monday. Trial for the drug will be conducted in the central Chinese city of Wuhan — ground zero of the viral outbreak that has so f...
Source: TIME: Health - February 3, 2020 Category: Consumer Health News Authors: Bloomberg Tags: Uncategorized 2019-nCoV Bloomberg onetime overnight Source Type: news

UK government pledges £20 million to help develop coronavirus vaccine
The funding will be used to support work to develop new vaccines for epidemics Related items fromOnMedica Warning on post-Brexit antibiotic use NHS review recommends making childhood vaccination more 'convenient' for parents Doctors can help overcome ‘vaccine hesitancy’ Global measles deaths reach historic low World ‘not prepared’ for Zika and Ebola (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 3, 2020 Category: UK Health Source Type: news

Wuhan Coronavirus Could Test the Trump Administration ’s Ability to Respond to a Crisis. Experts are Worried
As a new strain of coronavirus moves from the Wuhan province of China to other parts of the world, including the United States, public health leaders are advising government officials to embrace a deliberate, measured response. But with President Donald Trump at the helm of an often unpredictable administration, infectious disease and epidemic experts tell TIME they’re concerned about which officials will have the President’s ear, and how the Commander-in-Chief will manage his Twitter presence during a potential pandemic. On Friday, Health and Human Services Secretary Alex Azar announced that, against the advi...
Source: TIME: Health - January 31, 2020 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized 2019-nCoV Infectious Disease White House Source Type: news

‘There Are Sensible Voices That Are Emerging,’ How Scientists Are Using Social Media to Counter Coronavirus Misinformation
As a new form of coronavirus continues to infect a growing number of people around the world, medical professionals, scientists and big tech giants are fighting the spread of another contagion — misinformation. Just like a virus, it can be difficult to contain and many working in medical and scientific fields are using the very tools used to spread misinformation to counter it. Though so much misinformation is spread on platforms like Twitter and Facebook, Johns Hopkins Center for Health Security, and hundreds of other scientists and medical professionals who are studying the 2019 Novel Coronavirus, have been utilizi...
Source: TIME: Health - January 31, 2020 Category: Consumer Health News Authors: Jasmine Aguilera Tags: Uncategorized 2019-nCoV Infectious Disease onetime Source Type: news

The Coronavirus Outbreak Is Now a Public Health Emergency of International Concern. Here ’s What That Means
The World Health Organization (WHO) took the rare step Thursday of declaring a novel coronavirus outbreak that originated in Wuhan, China a public health emergency of international concern (PHEIC). But what does that actually mean? The WHO defines a PHEIC as an “extraordinary event” that “constitute[s] a public health risk to other States through the international spread of disease” and “potentially require[s] a coordinated international response.” Since that framework was defined in 2005—two years after another coronavirus, severe acute respiratory syndrome (SARS), spread through ...
Source: TIME: Health - January 30, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized 2019-nCoV public health Source Type: news

Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat
NEW BRUNSWICK, N.J., January 29, 2020 – Johnson & Johnson today announced that it is mobilizing resources at its Janssen Pharmaceutical Companies to launch a multi-pronged response to the novel coronavirus (also known as 2019-nCoV or Wuhan coronavirus) outbreak. As part of this work, the Company has initiated efforts to develop a vaccine candidate against 2019-nCoV and broadly collaborate with others to screen a library of antiviral therapies. Identifying compounds with antiviral activity against 2019-nCoV may contribute to providing immediate relief to the current outbreak.“J&J has a long-standing comm...
Source: Johnson and Johnson - January 29, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news

Coronavirus Death Toll Rises to 80 as U.S. Prepares to Evacuate Americans From Wuhan
(BEIJING) — A new viral illness being watched with a wary eye around the globe accelerated its spread in China with 80 deaths so far, while the U.S. Consulate in the city at the epicenter announced it will evacuate its personnel and some other Americans aboard a charter flight. China’s health minister said the country was entering a “crucial stage” as “it seems like the ability of the virus to spread is getting stronger.” Ma Xiaowei declined to estimate how long it would take to bring the situation under control, but said travel restrictions and other strict measures should bring results...
Source: TIME: Health - January 27, 2020 Category: Consumer Health News Authors: Ken Moritsugu / AP Tags: Uncategorized China Infectious Disease onetime overnight Source Type: news

The Wuhan Coronavirus Is Spreading Fast. Will Doctors Be Able to Find a Treatment Before the Outbreak Ends?
Cases of a novel pneumonia-like illness that originated in Wuhan, China in December have now been confirmed in South Korea, Thailand, Japan, Taiwan, Macau—and, as of Jan. 21, the U.S. The virus’ geographic reach, as well as its newly discovered ability to spread via person-to-person contact, has health officials worried about the prospect of globals spread. As health officials scramble to learn more about the virus and is origins, researchers are simultaneously turning to the question of how to develop a vaccine or therapy that could help contain transmission worldwide—a feat that experts say is technical...
Source: TIME: Health - January 22, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Infectious Disease Source Type: news

Canada's Ebola vaccine almost didn't happen, new study reveals
Dalhousie University professor Matthew Herder accessed hundreds of government documents to find out what really happened as Canadian scientists tried for years to get the pharmaceutical industry interested in their discovery of an Ebola vaccine. (Source: CBC | Health)
Source: CBC | Health - January 17, 2020 Category: Consumer Health News Tags: News/Health Source Type: news

Demystifying Medicine 2020: Ebola: Then, Now and the NIH (National Institutes of Health)
Source: National Institutes of Health (NIH). Published: 1/14/2020. This one-hour, 44-minute presentation discusses how the National Institutes of Health (NIH) has been at the forefront in the global effort to prevent the spread of Ebola virus. NIH staff were deployed in western Africa during the 2015-2016 Ebola outbreak to provide primary care to those infected, and Ebola patients were received at the NIH Clinical Center. For many years prior, NIH scientists studied the natural reservoirs of emerging viruses such as Ebola virus and have elucidated the biology of Ebola virus infection, which has informed the creation of in...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 14, 2020 Category: International Medicine & Public Health Source Type: news

PREVAC-UP: The Partnership for Research on Ebola Vaccination extends follow-up
(INSERM (Institut national de la sant é et de la recherche m é dicale)) Public health efforts successfully stopped human-to-human transmission of Ebola virus in West Africa in 2016 after the worst Ebola outbreak in history. Pursuing and intensifying efforts to develop a safe and effective vaccination strategy against Ebola virus disease, with durable protection in all populations, including children, is vital. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 13, 2020 Category: Infectious Diseases Source Type: news

Congo-Kinshasa: World's Biggest Measles Outbreak in DR Congo Kills Thousands
[Deutsche Welle] The deadly virus has killed nearly three times as many people in the Democratic Republic of Congo as any Ebola outbreak. It's preventable with a vaccine. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 8, 2020 Category: African Health Source Type: news

Staged Ebola pandemic being prepped for America, followed by mandatory Ebola vaccines using LIVE viral strains
(Natural News) An effort is under way right now to harvest Ebola-infected subjects from African nations, then transport them to the U.S. border and have them cross into the United States as “human weapons” who will unleash Ebola on U.S. soil. This is part of the globalist effort to bring down the United States of... (Source: NaturalNews.com)
Source: NaturalNews.com - January 4, 2020 Category: Consumer Health News Source Type: news

CDC and FDA "tag-teaming" Ebola bioweapons psy-op to push dangerous vaccines as part of an Ebola outbreak mass theater operation
(Natural News) The federal government is ramping up its Ebola propaganda campaign once again with a new announcement from the Centers for Disease Control and Prevention (CDC) about a newly released Ebola rapid diagnostics test, which just so happens to coincide with the release of a new Food and Drug Administration (FDA)-approved Ebola vaccine that... (Source: NaturalNews.com)
Source: NaturalNews.com - January 1, 2020 Category: Consumer Health News Source Type: news

Ervebo (Ebola Zaire Vaccine, Live Suspension for Intramuscular Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 27, 2019 Category: Drugs & Pharmacology Source Type: news

Congo-Kinshasa: DRC - Fighting Measles in Ebola-Affected Areas
[MSF] Dr. Nicolas Peyraud, a Doctors Without Borders/M édecins Sans Frontières (MSF) vaccination referent, has just returned from several assignments in the Democratic Republic of Congo (DRC), where he helped to set up measles vaccination campaigns in collaboration with UNICEF and the Congolese Ministry of Health. In areas also affected by the Ebola o utbreak, providing care for children suffering from with measles and vaccinating those at risk of contracting the disease pose additional challenges fo (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 24, 2019 Category: African Health Source Type: news

Merck Says Ebola Vaccine to Be Available at Lowest Access Price for Poor Nations Merck Says Ebola Vaccine to Be Available at Lowest Access Price for Poor Nations
Merck& Co said on Friday it expects to make licensed doses of its recently approved Ebola vaccine available in the third quarter of 2020 and price the single-dose injection at the lowest possible access price for poor and middle-income countries.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 24, 2019 Category: Consumer Health News Tags: Public Health & Prevention News Source Type: news

‘We can beat Ebola but must prepare for what comes next,’ says Wellcome Trust head
Jeremy Farrar, a world expert on diseases, tells of the fight against the deadly virus that spread fear this decade – and how to prepare for the health battles to comeJeremy Farrar, head of the Wellcome Trust, has a straightforward view about the way doctors and scientists tackled thecurrent Ebola epidemic in the Democratic Republic of the Congo. “In four or five years, we have taken a disease that was absolutely terrifying and which had an enormously high death rate – more than 80% – and we have turned it, potentially, into something that is preventable and treatable.”The fact this has been d...
Source: Guardian Unlimited Science - December 22, 2019 Category: Science Authors: Robin McKie Tags: Ebola Infectious diseases Vaccines and immunisation Medical research World news Source Type: news

FDA Approves Ebola Vaccine For USe And Distribution In United States
Although Ebola is rare in the U. S., the vaccine ’s approval will help in world-wide efforts to prevent future Ebola outbreaks and deaths. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 21, 2019 Category: Pharmaceuticals Authors: Dana Dovey, Contributor Source Type: news

Merck says Ebola vaccine to be available at lowest access price for poor nations
Merck& Co said on Friday it expects to make licensed doses of its recently approved Ebola vaccine available in the third quarter of 2020 and price the single-dose injection at the lowest possible access price for poor and middle-income countries. (Source: Reuters: Health)
Source: Reuters: Health - December 20, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Clears First Vaccine Against Deadly Ebola Virus FDA Clears First Vaccine Against Deadly Ebola Virus
The live (attenuated) Ervebo vaccine protects against Ebola virus disease caused by the Zaire strain of the Ebola virus is approved in people 18 and older.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 20, 2019 Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news

FDA OKs First Vaccine Against Deadly Ebola Virus FDA OKs First Vaccine Against Deadly Ebola Virus
The live (attenuated) Ervebo vaccine protects against Ebola virus disease caused by the Zaire strain of the Ebola virus is approved in people 18 and older.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 20, 2019 Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news

FDA Gives First Ebola Vaccine for Adults the Green Light
FRIDAY, Dec. 20, 2019 -- The first Ebola vaccine approved by the U.S. Food and Drug Administration is a single-dose injection called Ervebo. The vaccine from Merck& Co. is approved to protect against the Zaire ebolavirus in people ages 18 years... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 20, 2019 Category: Pharmaceuticals Source Type: news

FDA Gives First Ebola Vaccine for Adults the Green Light
The vaccine from Merck & Co. is approved to protect against the Zaire ebolavirus in people 18 and older. (Source: WebMD Health)
Source: WebMD Health - December 20, 2019 Category: Consumer Health News Source Type: news

US approves first Ebola vaccine amid West African outbreak of the deadly disease
On Thursday, the US Food and Drug Administration approved Ervebo, the first vaccine against Ebola to get green lit by American officials. It comes as a Congo outbreak rages on and has killed 4 in Uganda. (Source: the Mail online | Health)
Source: the Mail online | Health - December 20, 2019 Category: Consumer Health News Source Type: news

FDA Gives First Ebola Vaccine for Adults the Green Light
FRIDAY, Dec. 20, 2019 -- The first Ebola vaccine approved by the U.S. Food and Drug Administration is a single-dose injection called Ervebo. The vaccine from Merck& Co. is approved to protect against the Zaire ebolavirus in people 18 and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 20, 2019 Category: General Medicine Source Type: news

FDA approves first-ever vaccine for prevention of Ebola virus
The US Food and Drug administration has approved for the first time in the United States a vaccine for the prevention of the deadly Ebola virus, the agency announced Thursday. (Source: CNN.com - Health)
Source: CNN.com - Health - December 20, 2019 Category: Consumer Health News Source Type: news

Merck receives FDA approval for Ebola vaccine
The U.S. Food and Drug Administration said on Thursday it approved drugmaker Merck& Co's Ebola vaccine Ervebo, making it the first FDA-authorised vaccine against the deadly virus. (Source: Reuters: Health)
Source: Reuters: Health - December 20, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response
FDA announced today the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in individuals 18 years of age and older. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 20, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Approves Ervebo (Ebola Zaire Vaccine, Live) for the Prevention of Disease Caused by Zaire Ebolavirus
KENILWORTH, N.J.--(BUSINESS WIRE) December 20, 2019 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Ervebo® (Ebola Zaire Vaccine, Live)... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 19, 2019 Category: Drugs & Pharmacology Source Type: news

Congo-Kinshasa: 'Air Bridge' Vaccination Operation Begins for Ebola-Hit Communities
[UN News] The Democratic Republic of the Congo (DRC) has seen an increase in the number of reported cases of the deadly haemorrhagic virus Ebola linked to ongoing violence by armed groups targeting remote communities, the World Health Organization (WHO) said on Friday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 16, 2019 Category: African Health Source Type: news

‘Air bridge’ vaccination operation begins for Ebola-hit communities in DR Congo 
The Democratic Republic of the Congo (DRC) has seen an increase in the number of reported cases of the deadly haemorrhagic virus Ebola linked to ongoing violence by armed groups targeting remote communities, the World Health Organization (WHO) said on Friday.  (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - December 13, 2019 Category: International Medicine & Public Health Source Type: news

YSPH alumni play important roles in advancing Ebola vaccine
Swati Gupta ’97 M.P.H. and Anant Shah ’07 M.P.H. are at the forefront of the global fight against Ebola. (Source: Yale Science and Health News)
Source: Yale Science and Health News - December 10, 2019 Category: Universities & Medical Training Source Type: news

Rwanda: Rwanda, DR Congo to Vaccinate Over 700,000 People Against Ebola
[New Times] Rwanda and the Democratic Republic of the Congo Sunday unveiled a massive vaccination campaign against Ebola Virus Disease (EVD) for their residents who live within the vicinity of a possible Ebola outbreak. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 9, 2019 Category: African Health Source Type: news

Johnson & Johnson Announces Commitment to Support Republic of Rwanda ’s Preparedness Against Ebola Outbreak
Up to 200,000 Regimens of Janssen ’s Investigational Ebola Vaccine to be Supplied to Rwanda for Use in Border Region near Democratic Republic of the Congo (DRC) (Source: Johnson and Johnson)
Source: Johnson and Johnson - December 8, 2019 Category: Pharmaceuticals Source Type: news

Half a million Ebola vaccine doses to be stockpiled for emergency use
- A stockpile of 500,000 doses of Ebola vaccine for emergency use in outbreaks of the deadly fever is being established by the global vaccine alliance GAVI. (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Vaccine group announces creation of Ebola vaccine stockpile
Vaccine alliance announces creation of Ebola vaccine stockpile of about 500,000 doses (Source: ABC News: Health)
Source: ABC News: Health - December 5, 2019 Category: Consumer Health News Tags: Health Source Type: news

Congo-Kinshasa: Measles Vaccination Drive Launched, North Kivu Targets 2.2 Million Children
[WHO] Kinshasa, 5 December 2019 - Around 2.2 million children are to be vaccinated against measles in North Kivu, the Democratic Republic of the Congo (DRC), where efforts are underway to curb the world's second-worst Ebola outbreak amid persistent insecurity. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 5, 2019 Category: African Health Source Type: news

Congo-Kinshasa: Ebola Vaccinations in the Democratic Republic of the Congo - in the Community, By the Community
[WHO] The courtyard of the Musuniene Health Centre, normally quiet, rings with the sounds of adolescents running, playing and chatting in the open space, undaunted by the intense heat. The youth - all students at the Centre Professionnel Vusigha, a local technical school - are waiting for their turn to be vaccinated against the Ebola virus disease. Jean-Marie Kambale, their teacher, emerges from the health centre and proudly displays his vaccination certificate. "I am very happy because I am now protected agains (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 22, 2019 Category: African Health Source Type: news

Global health equity is needed to prevent an Ebola pandemic
Vaccinations, bed nets and oral rehydration help in the short term but are not solutions (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - November 21, 2019 Category: Pharmaceuticals Source Type: news

World Health Organization Chief Tedros Adhanom Ghebreyesus Never Stops Worrying
I am afraid for Dr. Tedros’ safety. The World Health Organization Director-General and I are walking from the WHO’s midtown-Manhattan offices to the nearby U.N. campus, where Tedros is participating in the U.N. General Assembly. As we cross avenues amid a chorus of honking horns, Tedros is so intent on answering my questions, rarely breaking eye contact, that he appears not to notice traffic lights changing and cyclists whizzing past at alarming proximity. His staff and I breathe a collective sigh of relief when he arrives at the U.N. unscathed. It should come as no surprise that the man at the helm of the worl...
Source: TIME: Health - November 21, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized climate change health World Health Organization Source Type: news